¥1,542.50
0.48%
Tokyo, Tue, Dec 30 2025
ISIN
JP3351100007
Symbol
6869

SYSMEX Stock price

¥1,542.50
+97.50 6.75% 1M
-970.12 38.61% 6M
-1,372.40 47.08% YTD
-1,372.40 47.08% 1Y
-1,121.42 42.10% 3Y
-2,587.61 62.65% 5Y
-1,065.46 40.85% 10Y
+1,167.79 311.65% 20Y
Tokyo, Closing price Tue, Dec 30 2025
-7.50 0.48%
ISIN
JP3351100007
Symbol
6869

New AI Insights on SYSMEX Insights AI Insights on SYSMEX

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
¥961.9b
Enterprise Value
¥939.1b
Net debt
positive
Cash
¥86.5b
Shares outstanding
623.2m
Valuation (TTM | estimate)
P/E
20.6 | 19.1
P/S
1.9 | 1.9
EV/Sales
1.9 | 1.8
EV/FCF
39.3
P/B
2.0
Dividends
DPS
¥38.00
Yield 1Y | 5Y
2.3% | 1.0%
Growth 1Y | 5Y
12.6% | 8.5%
Payout 1Y | 3Y
37.2% | 36.6%
Increased
5 Years
Financials (TTM | estimate)
Revenue
¥498.7b | ¥517.3b
EBITDA
¥118.7b | ¥123.6b
EBIT
¥76.0b | ¥94.4b
Net Income
¥46.7b | ¥50.3b
Free Cash Flow
¥23.9b
Growth (TTM | estimate)
Revenue
1.5% | 1.7%
EBITDA
-6.6% | -4.5%
EBIT
-14.6% | 4.5%
Net Income
-12.7% | -6.2%
Free Cash Flow
-25.4%
Margin (TTM | estimate)
Gross
52.8%
EBITDA
23.8% | 23.9%
EBIT
15.3%
Net
9.4% | 9.7%
Free Cash Flow
4.8%
Financial Health
Equity Ratio
69.7%
Return on Equity
11.6%
ROCE
13.5%
ROIC
9.7%
Debt/Equity
0.1
More
EPS
¥74.9
FCF per Share
¥38.3
Short interest
-
Employees
10k
Rev per Employee
¥50.7m
Show more

Is SYSMEX a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

SYSMEX Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a SYSMEX forecast:

18x Buy
82%
4x Hold
18%

Analyst Opinions

22 Analysts have issued a SYSMEX forecast:

Buy
82%
Hold
18%

Financial data from SYSMEX

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
498,691 498,691
2% 2%
100%
- Direct Costs 235,451 235,451
3% 3%
47%
263,240 263,240
0% 0%
53%
- Selling and Administrative Expenses 156,350 156,350
9% 9%
31%
- Research and Development Expense 29,419 29,419
7% 7%
6%
118,712 118,712
7% 7%
24%
- Depreciation and Amortization 42,674 42,674
12% 12%
9%
EBIT (Operating Income) EBIT 76,038 76,038
15% 15%
15%
Net Profit 46,686 46,686
13% 13%
9%

In millions JPY.

Don't miss a Thing! We will send you all news about SYSMEX directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Head office Japan
CEO Hisashi Ietsugu
Employees 10,042
Founded 1968
Website www.sysmex.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today